MicroRNA hsa-miR-4717-5p regulates RGS2 and may be a risk factor for anxiety-related traits

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 4, 2015, Pages 296-306

  Hommers, Leif ^a   Raab, Annette ^a   Bohl, Alexandra ^a   Weber, Heike ^a   Scholz, Claus Jürgen ^a   Erhardt, Angelika ^b   Binder, Elisabeth ^b   Arolt, Volker ^c   Gerlach, Alexander ^d   Gloster, Andrew ^e   Kalisch, Raffael ^f   Kircher, Tilo ^g   Lonsdorf, Tina ^h   Ströhle, Andreas ⁱ   Zwanzger, Peter ^c   Mattheisen, Manuel ^j   Cichon, Sven ^k,l,m   Lesch, Klaus Peter ^a   Domschke, Katharina ^a   Reif, Andreas ^a   Lohse, Martin J ⁿ   Deckert, Jürgen ^a   more..

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^g PHILIPPS UNIVERSITY MARBURG   (Germany)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j AARHUS UNIVERSITY   (Denmark)

^k UNIVERSITY OF BASEL   (Switzerland)

^l UNIVERSITY OF BONN   (Germany)

^m FORSCHUNGSZENTRUM JÜLICH   (Germany)

ⁿ UNIVERSITY OF WÜRZBURG   (Germany)

more..

Author keywords

Association; Gene regulation; MIR4717; miRNA; Panic disorder

Indexed keywords

HSA MICRORNA 22 3 P; HSA MICRORNA 3591 3P; HSA MICRORNA 377 3P; HSA MICRORNA 4717 5P; HSA MICRORNA 96 5P; LUCIFERASE; MICRORNA; RGS2 PROTEIN; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN4717 MICRORNA, HUMAN; RGS PROTEIN; RGS2 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGORAPHOBIA; AGORAPHOBIC COGNITIONS QUESTIONNAIRE; ALLELE; ANXIETY DISORDER; ANXIETY SENSITIVITY INDEX; ARTICLE; ASSESSMENT OF HUMANS; BIOINFORMATICS; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; HETEROZYGOTE; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MIDDLE AGED; PANIC; POINT MUTATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN PROCESSING; RECEPTOR DOWN REGULATION; REPORTER GENE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT; BIOLOGY; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; REPRODUCIBILITY; STATISTICAL MODEL;

RODENTIA;

3' UNTRANSLATED REGIONS; ADULT; AGORAPHOBIA; ALLELES; ANXIETY DISORDERS; CASE-CONTROL STUDIES; COMORBIDITY; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; LUCIFERASES; MALE; MICRORNAS; PANIC DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; RGS PROTEINS; RISK FACTORS;

EID: 84929519295     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32312     Document Type: Article

References (67)

1. Ambros V. 2004. The functions of animal microRNAs. Nature 431:350-355.
2. Amstadter AB, Koenen KC, Ruggiero KJ, Acierno R, Galea S, Kilpatrick DG, Gelernter J. 2009. Variant in RGS2 moderates posttraumatic stress symptoms following potentially traumatic event exposure. J Anxiety Disord 23:369-373.
3. Baumann C, Klauke B, Weber H, Domschke K, Zwanzger P, Pauli P, Deckert J, Reif A. 2013. The interaction of early life experiences with COMT val158met affects anxiety sensitivity. Genes Brain Behav 12:821-829.
4. Betel D, Koppal A, Agius P, Sander C, Leslie C. 2010. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11:R90.
5. Bhattacharya A, Ziebarth JD, Cui Y. 2014. PolymiRTS Database 3.0: Linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways. Nucleic Acids Res 42:D86-D91.
6. Boudreau RL, Jiang P, Gilmore BL, Spengler RM, Tirabassi R, Nelson JA, Ross CA, Xing Y, Davidson BL. 2014. Transcriptome-wide discovery of microRNA binding sites in human brain. Neuron 81:294-305.
7. Dias BG, Banerjee SB, Goodman JV, Ressler KJ. 2015. Towards new approaches to disorders of fear and anxiety. Curr Oppin Neurobiol 23: in press.
8. Chambless DL, Caputo GC, Bright P, Gallagher R. 1984. Assessment of fear of fear in agoraphobics: The body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 52:1090-1097.
9. Cross-Disorder Group of the Psychiatric Genomics Consortium 2013. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. The Lancet 381:1371-1379.
10. Dias BG, Banerjee SB, Goodman JV, Ressler KJ. 2013. Towards new approaches to disorders of fear and anxiety. Curr Opin Neurobiol 23:346-352.
11. Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder EB, Holsboer F, Gerlach AL, Kircher T, Lang T, Alpers GW, Ströhle A, Fehm L, Gloster AT, Wittchen HU, Arolt V, Pauli P, Hamm A, Deckert J. 2011. Neuropeptide S receptor gene -converging evidence for a role in panic disorder. Mol Psychiatry 16:938-948.
12. Domschke K, Deckert J. 2012. Genetics of anxiety disorders-status quo and quo vadis. Curr Pharm Des 18:5691-5698.
13. Dweep H, Sticht C, Pandey P, Gretz N. 2011. MiRWalk-database: Prediction of possible miRNA binding sites by "walking" the genes of 3 genomes. J Biom Inform 44:839-847.
14. Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, Specht M, Kohli MA, Kloiber S, Ising M, Heck A, Pfister H, Zimmermann P, Lieb R, Pütz B, Uhr M, Weber P, Deussing JM, Gonik M, Bunck M, Kebler MS, Frank E, Hohoff C, Domschke K, Krakowitzky P, Maier W, Bandelow B, Jacob C, Deckert J, Schreiber S, Strohmaier J, Nöthen M, Cichon S, Rietschel M, Bettecken T, Keck ME, Landgraf R, Müller-Myhsok B, Holsboer F, Binder EB. 2011. TMEM132D, a new candidate for anxiety phenotypes: Evidence from human and mouse studies. Mol Psychiatry 16:647-663.
15. Flint J. 2003. Analysis of quantitative trait loci that influence animal behaviour. J Neurobiol 54:46-77.
16. Flint J, Mott R. 2008. Applying mouse complex-trait resources to behavioural genetics. Nature 456:724-727.
17. Gloster AT, Wittchen H-U, Einsle F, Höfler M, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Gerlach AL, Ströhle A, Kircher T, Deckert J, Zwanzger P, Arolt V. 2009. Mechanism of action in CBT (MAC): Methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. Eur Arch Psychiatry Clin Neurosci 259(Suppl 2):S155-S166.
18. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. 2007. MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing. Mol Cell 27:91-105.
19. 2+ channels. Neuron 51:575-586.
20. Han M, Zheng Y. 2013. Comprehensive analysis of single nucleotide polymorphisms in human microRNAs. PLoS ONE 8:e78028.
21. Hanin G, Shenhar-Tsarfaty S, Yayon N, Yau YH, Hoe YY, Bennett ER, Sklan EH, Rao DC, Rankinen T, Bouchard C, Geifman-Shochat S, Shifman S, Greenberg DS, Soreq H. 2014. Competing targets of microRNA-608 affect anxiety and hypertension. Hum Mol Genet 23:4569-4580.
22. Heximer SP. 2004. RGS2-mediated regulation of Gqalpha. Methods Enzymol 390:65-82.
23. Hettema JM, Sun C, Chen X, Kendler KS. 2013. Genetic association study between RGS2 and anxiety-related phenotypes. Psychiatr Genet 23:92.
24. Hohoff C, Weber H, Richter J, Domschke K, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob CP, Maier W, Fritze J, Bandelow B, Gloster AT, Gerlach AL, Kircher T, Lang T, Alpers GW, Ströhle A, Fehm L, Wittchen HU, Arolt V, Pauli P, Hamm A, Reif A, Deckert J. 2014. RGS2 genetic variation: Association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxiety. Am J Med Genet B Neuropsychiatr Genet in press.
25. Jensen KP, Covault J, Conner TS, Tennen H, Kranzler HR, Furneaux HM. 2009. A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors. Mol Psychiatry 14:381-389.
26. Jensen KP, Covault J. 2011. Human miR-1271 is a miR-96 paralog with distinct non-conserved brain expression pattern. Nucleic Acids Res 39:701-711.
27. Johnson AD, Handsaker RE, Pulit S, Nizzari MM, O'Donnell CJ, de Bakker PIW. 2008. SNAP: A web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24:2938-2939.
28. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. 2007. The role of site accessibility in microRNA target recognition. Nat Genet 39:1278-1284.
29. Koenen KC, Amstadter AB, Ruggiero KJ, Acierno R, Galea S, Kilpatrick DG, Gelernter J. 2009. RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress Anxiety 26:309-315.
30. Kozomara A, Griffiths-Jones S. 2014. MirBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42:D68-D73.
31. Leygraf A, Hohoff C, Freitag C, Willis-Owen SA, Krakowitzky P, Fritze J, Franke P, Bandelow B, Fimmers R, Flint J, Deckert J. 2006. RGS 2 gene polymorphisms as modulators of anxiety in humans?. J Neural Transm 113:1921-1925.
32. Lesch KP, Waider J. 2012. Serotonin in the modulation of neural plasticity and networks: Implications for neurodevelopmental disorders. Neuron 76:175-191.
33. Lifschytz T, Broner EC, Zozulinsky P, Slonimsky A, Eitan R, Greenbaum L, Lerer B. 2011. Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: Serotonergic involvement. Int J Neuropsychopharmacol 15:1307-1318.
34. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769-773.
35. Lu TP, Lee CY, Tsai MH, Chiu YC, Hsiao CK, Lai LC, Chuang EY. 2012. MiRSystem: An integrated system for characterizing enriched functions and pathways of MicroRNA targets. PLoS ONE 7:e42390.
36. Malan-Müller S, Hemmings SMJ, Seedat S. 2013. Big Effects of Small RNAs: A Review of MicroRNAs in Anxiety. Mol Neurobiol 47:726-739.
37. Maron E, Hettema JM, Shlik J. 2010. Advances in molecular genetics of panic disorder. Mol Psychiatry 15:681-701.
38. Mattheisen M, Samuels JF, Wang Y, Greenberg BD, Fyer AJ, McCracken JT, Geller DA, Murphy DL, Knowles JA, Grados MA, Riddle MA, Rasmussen SA, McLaughlin NC, Nurmi EL, Askland KD, Qin H-D, Cullen BA, Piacentini J, Pauls DL, Bienvenu OJ, Stewart SE, Liang K-Y, Goes FS, Maher B, Pulver AE, Shugart YY, Valle D, Lange C, Nestadt G. 2014. Genome-wide association study in obsessive-compulsive disorder: Results from the OCGAS. Mol Psychiatry advanced online publication 13 May 2014.
39. McVean GA on behalf of the1000 Genomes Project Consortium 2012. An integrated map of genetic variation from 1, 092 human genomes. Nature 491:56-65.
40. Menashe I, Rosenberg PS, Chen BE. 2008. PGA: Power calculator for case-control genetic association analyses. BMC Genet 9:36.
41. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I,. 2006. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126:1203-1217.
42. Mouri K, Hishimoto A, Fukutake M, Nishiguchi N, Shirakawa O, Maeda K. 2010. Association study of RGS2 gene polymorphisms with panic disorder in Japanese. Kobe J Med Sci 55:E116-E121.
43. Muiños-Gimeno M, Guidi M, Kagerbauer B, Martín-Santos, Navineés R, Alonso P, Menchón, Gratacòs M, Estivill X, Espinosa-Parrilla Y. 2009. Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum Mutat 30:1062-1071.
44. Muiños-Gimeno M, Espinosa-Parrilla Y, Guidi M, Kagerbauer B, Sipila T, Maron E, Pettai K, Kananen L, Navinés R, Martín-Santos R, Gratacòs M, Metspalu A, Hovatta I, Estivill X. 2011. Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol Psych 69:526-533.
45. Oliveira-dos-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, Whishaw IQ, Mariathasan S, Sasaki T, Wakeham A, Ohashi PS, Roder JC, Barnes CA, Siderovski DP, Penninger JM. 2000. Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci USA 97:12272-12277.
46. Otowa T, Shimada T, Kawamura Y, Sugaya N, Yoshida E, Inoue K, Yasuda S, Liu X, Minato T, Tochigi M, Umekage T, Kasai K, Tanii H, Okazaki Y, Kaiya H, Sasaki T. 2011. Association of RGS2 variants with panic disorder in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 156B:430-434.
47. Paraskevopoulou MD, Georgakilas G, Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, Filippidis C, Dalamagas T, Hatzigeorgiou AG. 2013. DIANA-microT web server v5.0: Service integration into miRNA functional analysis workflows. Nucleic Acids Res 41:W169-W173.
48. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PJ. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
49. Reif A, Weber H, Domschke K, Klauke B, Baumann C, Jacob CP, Ströhle A, Gerlach AL, Alpers GW, Pauli P, Hamm A, Kircher T, Arolt V, Wittchen HU, Binder EB, Erhardt A, Deckert J. 2012. Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations. Am J Med Genet B Neuropsychiatr Genet 159B:786-793.
50. Reif A, Richter J, Straube B, Höfler M, Lueken U, Gloster AT, Weber H, Domschke K, Fehm L, Ströhle A, Jansen A, Gerlach A, Pyka M, Reinhardt I, Konrad C, Wittmann A, Pfleiderer B, Alpers GW, Pauli P, Lang T, Arolt V, Wittchen H-U, Hamm A, Kircher T, Deckert J. 2014. MAOA and machnisms of panic disorder revisited: From bench to molecular psychotherapy. Mol Psychiatry 19:122-128.
51. Reiss S, Peterson RA, Gursky DM, McNally RJ. 1986. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 24:1-8.
52. Rietschel M, Mattheisen M, Degenhardt F, Genetic Risk and Outcome in Psychosis (GROUP Investigators), Mühleisen TW, Kirsch P, Esslinger C, Herms S, Demontis D, Steffens M, Strohmaier J, Haenisch B, Breuer R, Czerski PM, Giegling I, Strengman E, Schmael C, Mors O, Mortensen PB, Hougaard DM, Ørntoft T, Kapelski P, Priebe L, Basmanav FF, Forstner AJ, Hoffman P, Meier S, Nikitopoulos J, Moebus S, Alexander M, Mössner R, Wichmann H-, Schreiber S, Rivandeneira F, Hofman A, Uitterlinden AG, Wienker TF, Schumacher J, Hauser J, Maier W, Cantor RM, Erk S, Schulze TG; SGENE-plus Consortium, Craddock N, Owen MJ, O'Donovan MC, Børglum AD, Rujescu D, Walter H, Meyer-Lindenberg A, Nöthen NM, Ophoff RA, Cichon S. 2012. Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. 2012. Mol Psychiatry 17:906-917.
53. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Towle LH. 1988. The Composite International Diagnostic Interview. An epidemiological instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45:1069-1077.
54. Sheehan DV, Lecrubier Y, Shehan KH, Amorim P, Janavs J, Weiler E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22-33.
55. Smoller JW, Paulus MP, Fagerness JA, Purcell S, Yamaki LH, Hirshfeld-Becker D, Biederman J, Rosenbaum JF, Gelernter J, Stein MB. 2008. Influence of RGS2 on anxiety-related temperament, personality, and brain function. Arch Gen Psychiatry 65:298-308.
56. Stein MB, Keshaviah A, Haddad SA, Van Ameringen M, Simon NM, Pollack MH, Smoller JW. 2014. Influence of RGS2 on sertraline treatment for social anxiety disorder. Neuropsychopharmacol 39:1340-1346.
57. Stewart SE, et al. 2013. Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry 18:788-798.
58. Strug LJ, Suresh R, Fyer AJ, Talati A, Adams PB, Li W, Hodge SE, Gilliam TC, Weissman MM. 2010. Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Mol Psychiatry 15:166-176.
59. Tam A, Lee KS, Lee S, Burkhalter W, Pascua LU, Slavin TP. 2013. Bilateral radial ulnar synostosis and vertebral anomalies in a child with a de novo 16p13.3 interstitial deletion. Case Rep Genet 2013:149085.
60. Talbot CJ, Nicod A, Cherny SS, Fulker DW, Collins AC, Flint J. 1999. High-resolution mapping of quantitative trait loci in outbred mice. Nat Genet 21:305-308.
61. The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium 2011. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43:969-976.
62. Wang X, El Naqa IM. 2008. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24:325-332.
63. Watson N, Linder ME, Druey KM, Kehrl JH, Blumer KJ. 1996. RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Nature 383:172-175.
64. Weber H, Scholz CJ, Domschke K, Baumann C, Klauke B, Jacob CP, Maier W, Fritze J, Bandelow B, Zwanzger PM, Lang T, Fehm L, Ströhle A, Hamm A, Gerlach AL, Alpers GW, Kircher T, Wittchen HU, Arolt V, Pauli P, Deckert J, Reif A. 2012. Gender differences in associations of glutamate decarboxylase 1 gene (GAD1) variants with panic disorder. PLoS One 7:e37651.
65. Wittchen HU, Garczynski E, Pfister H. 1997. Composite international diagnostic interview according to ICD-10 and DSM-IV. Göttingen: Hogrefe.
66. Yalcin B, Willis-Owen SAG, Fullerton J, Meesaq A, Deacon RM, Rawlins JNP, Copley RR, Morris AP, Flint J, Mott R. 2004. Genetic dissection of a behavioral quantitative trait locus shows that RGS2 modulates anxiety in mice. Nat Genet 36:1197-11202.
67. Ziats MN, Rennert OM. 2014. Identification of differentially expressed microRNAs across the developing human brain. Mol Psychiatry 19:848-852.